AbstractObjectivesThe purpose of study was to report the clinical improvement of late complications of COVID-19 patient complaining of dyspnea treated with Korean medicine pulmonary rehabilitation.
MethodsTo assess the treatment outcomes, we used the modified medical research council scale (mMRC), 6-minute walk distance (6MWD), peak expiratory flow rate (PEFR), St. George respiratory questionnaire (SGRQ).
참고문헌1. WHO. Who director-general’s opening remarks at the media briefing on covid-19-11 march 2020 [internet]. Geneva: World health organization;2020. [cited 2020 mar 11]. Available from: https://www.Who.Int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefingon-covid-19---11-march-2020
2. SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, & Barzegary A, et al. (2021). Late complications of covid-19; a systematic review of current evidence. Archives of academic emergency medicine;9(1):
3. Kim D-s, Chu H, Min BK, Moon Y, Park S, & Kim K, et al. (2020). Telemedicine center of korean medicine for treating patients with covid-19: A retrospective analysis. Integrative medicine research;9(3):100492
4. Lee S, Park J, Lee Y-j, Kim S-h, & Lee J. (2021). A case report of taeeumin with post covid-19 syndrome. Journal of Sasang Constitutional Medicine;33(4):32-42.
5. Fletcher CM, Elmes PC, Fairbairn AS, & Wood CH. (1959). Significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. British medical journal;2(5147):257
6. Puhan MA, Mador M, Held U, Goldstein R, Guyatt G, & Schünemann H. (2008). Interpretation of treatment changes in 6-minute walk distance in patients with copd. European Respiratory Journal;32(3):637-643.
7. Gibson PG. (2002). Outpatient monitoring of asthma. Current Opinion in Allergy and Clinical Immunology;2(3):161-166.
8. Jones P, Quirk F, & Baveystock C. (1991). The st george’s respiratory questionnaire. Respiratory medicine;85(25–31):discussion 33.
9. Moreno-Pérez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, & Arenas-Jiménez J, et al. (2021). Post-acute covid-19 syndrome. Incidence and risk factors: A mediterranean cohort study. Journal of Infection;82(3):378-383.
10. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, & Stevens JS, et al. (2021). Post-acute covid-19 syndrome. Nature medicine;27(4):601-615.
11. Carfì A, Bernabei R, & Landi F. (2020). Persistent symptoms in patients after acute covid-19. Jama;324(6):603-605.
12. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, & Gouze H, et al. (2020). Post-discharge persistent symptoms and health-related quality of life after hospitalization for covid-19. Journal of Infection;81(6):e4-e6.
13. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, & McLean L, et al. (2021). Postdischarge symptoms and rehabilitation needs in survivors of covid-19 infection: A cross-sectional evaluation. Journal of medical virology;93(2):1013-1022.
14. Chopra V, Flanders SA, O’Malley M, Malani AN, & Prescott HC. (2021). Sixty-day outcomes among patients hospitalized with covid-19. Annals of Internal Medicine;174(4):576-578.
15. Lee K, Jeong S, Jeong M, Choi Y, Song M, & Jang I. (2021). Review on herbal medicine treatment for late complications of covid-19 patients. The Journal of Internal Korean Medicine;42(1):53-66.
16. Lee SW, Park JJ, Lyu YR, Lee EJ, Kim SY, & Kang W, et al. (2022). The effect of lung-conduction exercise in chronic obstructive pulmonary disease: Randomized, assessor-blind, multicenter pilot trial. Medicine;101(3):
|
|